125 related articles for article (PubMed ID: 9333149)
41. [Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis].
He S; Huang H
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):526-8. PubMed ID: 10436957
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha.
Karsten V; Gordon S; Kirn A; Herbein G
Immunology; 1996 May; 88(1):55-60. PubMed ID: 8707350
[TBL] [Abstract][Full Text] [Related]
43. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
[TBL] [Abstract][Full Text] [Related]
44. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
45. Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha.
Xiao L; Owen SM; Rudolph DL; Lal RB; Lal AA
J Infect Dis; 1998 Feb; 177(2):437-45. PubMed ID: 9466533
[TBL] [Abstract][Full Text] [Related]
46. In vitro effects of recombinant TNF-alpha binding protein (rTBP-1) on hematopoiesis of HIV-infected patients.
Gradstein S; Hahn T; Barak Y; Malach L; Revel M; Bentwich Z; Handzel ZT
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):111-7. PubMed ID: 11242177
[TBL] [Abstract][Full Text] [Related]
47. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
Sulkowski MS; Chaisson RE; Karp CL; Moore RD; Margolick JB; Quinn TC
J Infect Dis; 1998 Dec; 178(6):1642-8. PubMed ID: 9815216
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis factor-alpha and nitric oxide in vertically HIV-1-infected children: implications for pathogenesis.
González-Nicolás J; Resino S; Jiménez JL; Alvarez S; Fresno M; Muñoz-Fernández MA
Eur Cytokine Netw; 2001; 12(3):437-44. PubMed ID: 11566624
[TBL] [Abstract][Full Text] [Related]
49. Membrane expression and shedding of tumour necrosis factor receptors during activation of human blood monocytes: regulation by desferrioxamine.
Philippe C; Roux-Lombard P; Fouqueray B; Perez J; Dayer JM; Baud L
Immunology; 1993 Oct; 80(2):300-5. PubMed ID: 8262558
[TBL] [Abstract][Full Text] [Related]
50. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
51. The heavy metal lead modulates the expression of both TNF-alpha and TNF-alpha receptors in lipopolysaccharide-activated human peripheral blood mononuclear cells.
Guo TL; Mudzinski SP; Lawrence DA
J Leukoc Biol; 1996 Jun; 59(6):932-9. PubMed ID: 8691080
[TBL] [Abstract][Full Text] [Related]
52. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequences.
Aukrust P; Lien E; Kristoffersen AK; Müller F; Haug CJ; Espevik T; Frøland SS
Blood; 1996 Jan; 87(2):674-81. PubMed ID: 8555490
[TBL] [Abstract][Full Text] [Related]
53. Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.
Olas K; Butterweck H; Teschner W; Schwarz HP; Reipert B
Clin Exp Immunol; 2005 Jun; 140(3):478-90. PubMed ID: 15932509
[TBL] [Abstract][Full Text] [Related]
54. Effect of nutrition on tumor necrosis factor receptors in weight-gaining and -losing rats.
Raina N; Lamarre J; Liew CC; Lofti AH; Jeejeebhoy KN
Am J Physiol; 1999 Sep; 277(3):E464-73. PubMed ID: 10484358
[TBL] [Abstract][Full Text] [Related]
55. Modulation of lymphocyte and monocyte activity after intravenous immunoglobulin administration in vivo.
Aukrust P; Müller F; Nordøy I; Haug CJ; Frøland SS
Clin Exp Immunol; 1997 Jan; 107(1):50-6. PubMed ID: 9010256
[TBL] [Abstract][Full Text] [Related]
56. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.
Aukrust P; Frøland SS; Liabakk NB; Müller F; Nordøy I; Haug C; Espevik T
Blood; 1994 Oct; 84(7):2136-43. PubMed ID: 7919327
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.
Wu KH; Wu WM; Lu MY; Chiang BL
Pediatr Allergy Immunol; 2006 Feb; 17(1):60-8. PubMed ID: 16426257
[TBL] [Abstract][Full Text] [Related]
58. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
Bemelmans MH; Gouma DJ; Buurman WA
J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
[TBL] [Abstract][Full Text] [Related]
59. A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality.
Pellegrini JD; Puyana JC; Lapchak PH; Kodys K; Miller-Graziano CL
Shock; 1996 Dec; 6(6):389-96. PubMed ID: 8961387
[TBL] [Abstract][Full Text] [Related]
60. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors.
Rieckmann P; Poli G; Fox CH; Kehrl JH; Fauci AS
J Immunol; 1991 Nov; 147(9):2922-7. PubMed ID: 1918999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
